Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.

MLA

Di Forti, Marta, et al. “Proportion of Patients in South London with First-Episode Psychosis Attributable to Use of High Potency Cannabis: A Case-Control Study.” The Lancet. Psychiatry, vol. 2, no. 3, Mar. 2015, pp. 233–38. EBSCOhost, https://doi.org/10.1016/S2215-0366(14)00117-5.

APA

Di Forti, M., Marconi, A., Carra, E., Fraietta, S., Trotta, A., Bonomo, M., Bianconi, F., Gardner-Sood, P., O’Connor, J., Russo, M., Stilo, S. A., Marques, T. R., Mondelli, V., Dazzan, P., Pariante, C., David, A. S., Gaughran, F., Atakan, Z., Iyegbe, C., … Murray, R. M. (2015). Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. The Lancet. Psychiatry, 2(3), 233–238. https://doi.org/10.1016/S2215-0366(14)00117-5

Chicago

Di Forti, Marta, Arianna Marconi, Elena Carra, Sara Fraietta, Antonella Trotta, Matteo Bonomo, Francesca Bianconi, et al. 2015. “Proportion of Patients in South London with First-Episode Psychosis Attributable to Use of High Potency Cannabis: A Case-Control Study.” The Lancet. Psychiatry 2 (3): 233–38. doi:10.1016/S2215-0366(14)00117-5.